Humanized antibody binding to claudin for treating cancer
A technology of humanized antibodies and claudin, applied in the direction of antibodies, immunoglobulins, anti-animal/human immunoglobulins, etc., can solve problems such as tight junction damage and Claudin18.2 unable to perform normal functions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0092] 1. Definition:
[0093]An "antibody" as used herein is an immunoglobulin molecule consisting of four peptide chains, two heavy (H) chains and two light (L) chains interconnected by disulfide bonds, each heavy chain comprising a heavy chain variable region ( HVR or VH) and a heavy chain constant region, the heavy chain constant region contains three domains CH1, CH2 and CH3, each light chain includes a light chain variable region (LVR or VL) and a light chain constant region, a light chain constant region Consisting of one domain (CL1), the VH and VL regions can be further divided into hypervariable regions called complementarity determining regions (CDRs), interspersed with more conserved regions called framework regions (FRs), each VH and VL consists of three CDRs and four FRs, arranged in the following order from amino-terminus to carboxy-terminus: FR1, CDR1, FR2, CDR2, FR3, CDR3, FR4. Herein, the heavy chain constant region may be selected from IgG1, IgG2, IgG3 or I...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com